MentalHealthDaily

Prader-Willi Syndrome: New Treatments & Medications in Development & Clinical Trials (2023)

Prader-Willi Syndrome (PWS) is a rare genetic condition marked by a diverse range of physical, mental, and behavioral challenges. Characterized by uncontrolled appetite and obesity, cognitive impairments, and social and behavioral issues, PWS presents unique challenges for patients and caregivers. Highlights: Prevalence and Genetics: PWS affects approximately 1 in 20,000 live births, caused by errors …

Advanced OCD Treatment Strategies & New Drugs Under Investigation (2023)

by GLOOM

OCD affects approximately 1-3% of the population and often begins in childhood or adolescence. While OCD was previously considered untreatable, advances in the past few decades have led to effective evidence-based treatments. Key Facts: Glutamatergic medications like memantine, ketamine, and N-acetylcysteine have shown preliminary evidence of efficacy in small trials, but larger studies have been …